AlphaFold predicted structure
XYLT2 · Q9H1B5

Mean pLDDT
83.9/ 100
Confident
865 residues
Confidence breakdown
- Very high(≥ 90)70%
- Confident(70–90)11%
- Low(50–70)5%
- Very low(< 50)14%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
xylosyltransferase 2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Bilateral congenital or childhood onset cataracts
BIALLELIC, autosomal or pseudoautosomalCongenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
+1 more panels — install the extension to see the full list inline on any page.
spondylo-ocular syndrome
Pseudoxanthoma elasticum
hereditary disease
osteogenesis imperfecta
autosomal recessive inherited pseudoxanthoma elasticum
nephronophthisis
renal cysts and diabetes syndrome
progressive familial intrahepatic cholestasis
Senior-Boichis syndrome
Isolated polycystic liver disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Xylosyltransferase 2
Catalyzes the first step in the biosynthesis of chondroitin sulfate, heparan sulfate and dermatan sulfate proteoglycans, such as DCN. Transfers D-xylose from UDP-D-xylose to specific serine residues of the core protein
XYLT2 · Q9H1B5

Mean pLDDT
83.9/ 100
Confident
865 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0